These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 24951107)
1. Complexities of androgen receptor signalling in breast cancer. McNamara KM; Moore NL; Hickey TE; Sasano H; Tilley WD Endocr Relat Cancer; 2014 Aug; 21(4):T161-81. PubMed ID: 24951107 [TBL] [Abstract][Full Text] [Related]
2. Secreted indicators of androgen receptor activity in breast cancer pre-clinical models. Hanamura T; Christenson JL; O'Neill KI; Rosas E; Spoelstra NS; Williams MM; Richer JK Breast Cancer Res; 2021 Nov; 23(1):102. PubMed ID: 34736512 [TBL] [Abstract][Full Text] [Related]
3. Bringing androgens up a NOTCH in breast cancer. Tarulli GA; Butler LM; Tilley WD; Hickey TE Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242 [TBL] [Abstract][Full Text] [Related]
4. Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma. Kikuchi K; McNamara KM; Miki Y; Moon JY; Choi MH; Omata F; Sakurai M; Onodera Y; Rai Y; Ohi Y; Sagara Y; Miyashita M; Ishida T; Ohuchi N; Sasano H Breast Cancer Res Treat; 2017 Dec; 166(3):709-723. PubMed ID: 28831645 [TBL] [Abstract][Full Text] [Related]
5. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer. Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566 [TBL] [Abstract][Full Text] [Related]
6. The Role of the Androgen Receptor Signaling in Breast Malignancies. Christopoulos PF; Vlachogiannis NI; Vogkou CT; Koutsilieris M Anticancer Res; 2017 Dec; 37(12):6533-6540. PubMed ID: 29187427 [TBL] [Abstract][Full Text] [Related]
7. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells. De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907 [TBL] [Abstract][Full Text] [Related]
8. Editorial: The Androgen Receptor in Breast Cancer. Tesei A; Castoria G Front Endocrinol (Lausanne); 2020; 11():636480. PubMed ID: 33519718 [No Abstract] [Full Text] [Related]
10. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review. Jahan N; Jones C; Rahman RL Mol Cell Endocrinol; 2021 Jul; 531():111324. PubMed ID: 34000352 [TBL] [Abstract][Full Text] [Related]
11. Role of the androgen receptor in triple-negative breast cancer. Rampurwala M; Wisinski KB; O'Regan R Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor signaling pathways as a target for breast cancer treatment. Pietri E; Conteduca V; Andreis D; Massa I; Melegari E; Sarti S; Cecconetto L; Schirone A; Bravaccini S; Serra P; Fedeli A; Maltoni R; Amadori D; De Giorgi U; Rocca A Endocr Relat Cancer; 2016 Oct; 23(10):R485-98. PubMed ID: 27528625 [TBL] [Abstract][Full Text] [Related]
13. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor. Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393 [TBL] [Abstract][Full Text] [Related]
14. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action. Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548 [No Abstract] [Full Text] [Related]
15. Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease. Barton VN; D'Amato NC; Gordon MA; Christenson JL; Elias A; Richer JK Horm Cancer; 2015 Dec; 6(5-6):206-13. PubMed ID: 26201402 [TBL] [Abstract][Full Text] [Related]
16. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells. Lin HY; Sun M; Lin C; Tang HY; London D; Shih A; Davis FB; Davis PJ J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):182-8. PubMed ID: 19159686 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer. Liu WJ; Zhao G; Zhang CY; Yang CQ; Zeng XB; Li J; Zhu K; Zhao SQ; Lu HM; Yin DC; Lin SX J Cell Biochem; 2020 Apr; 121(4):2756-2769. PubMed ID: 31693255 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol synthesis inhibitor RO 48-8071 suppresses transcriptional activity of human estrogen and androgen receptor. Mafuvadze B; Liang Y; Hyder SM Oncol Rep; 2014 Oct; 32(4):1727-33. PubMed ID: 25051231 [TBL] [Abstract][Full Text] [Related]